Abstract
Heart failure is associated with persistent sympathetic stimulation and inflammation, causing an induced insulin resistance creating a need for higher doses of insulin. We hypothesized that cortisol and chatecholamine levels would be elevated in end stage heart failure patients, however, would be reduced after the implantation of a left ventricular assist device (LVAD). Insulin requirements and diabetic control would also be reduced post LVAD implant.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation
Paper Title
Journal
Date
